Pharma Journalist - Page 903 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA approves Prometics PBI-4050 Clinical trial design

Ionis Ribo enters a collaboration for RNA targeted Therapeutics

Gerrit Dispersyn RXI pharmaceuticals NEW Chief Development Officer

Rigel Submits NDA to FDA for Fostamatinib in Chronic ITP

Allergan & Novartis enters a clinical collaboration for NASH treatment

Inovio Pharmaceuticals to Implement Pilgrim Quality Solutions in the Cloud

Grifols Donates 140 Million IU of Blood Clotting Factors to the WFH Humanitarian Aid Program

Zymeworks Receives Second Orphan Drug Designation for ZW25 in Gastric Cancer

Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya

BioCryst to explore oral liquid formulation of BCX7353 for use in Acute HAE attacks